sr-31747 has been researched along with Sepsis* in 1 studies
1 other study(ies) available for sr-31747 and Sepsis
Article | Year |
---|---|
Reduction of IL-10 and nitric oxide synthesis by SR31747A (sigma ligand) in RAW murine macrophages.
There are several subtypes of sigma receptor, one of which is found throughout the immune system. SR31747A is a unique sigma ligand that possesses potent immune modulatory properties. Previous in vivo studies have documented that administration of SR31747A in murine models of sepsis resulted in decreased proinflammatory (IL-1, IL-6, TNF-alpha) and increased anti-inflammatory (IL-10) response (serum, splenocyte). Studies regarding the effect of this sigma ligand on purified macrophages are lacking. We therefore sought to investigate the effect of SR31747A in LPS-stimulated murine macrophages (RAW 264.7).. RAW cells were incubated at 2.5 x 10(5) cells/well; controls were incubated with media alone, experimental groups contained LPS (0.01 microg) and SR31747A (1 nM, 10 nM, 100 nM, 1 microM, 10 microM). Supernatant and cells were harvested at 24 and 48 h. Concentrations of nitric oxide (Greiss reaction) and IL-10 were determined in the supernatant; cellular IL-10 mRNA was assessed.. SR31747A induced a dose-dependent reduction in NO and IL-10 protein release in LPS-stimulated murine macrophages. The decrease in IL-10 protein synthesis was paralleled by a significant dose-dependent reduction in IL-10 mRNA.. SR31747A is a novel immunomodulator that down regulates nitric oxide and IL-10 protein and mRNA expression. This in vitro reduction of IL-10 protein and mRNA expression is in contrast to previous in vivo murine studies. These data suggest that peripheral macrophages are not the source of the increased anti-inflammatory (IL-10) response induced by SR31747A. Topics: Animals; Cyclohexanes; Disease Models, Animal; In Vitro Techniques; Interleukin-10; Ligands; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide Synthase; Receptors, sigma; RNA, Messenger; Sepsis; Time Factors | 2001 |